Obstetrx creates a uterine tamponade device to eliminate maternal death and disability from postpartum hemorrhage.
Obstetrx has raised $1.1M in total funding. The most recent round was Angel. The last funding was announced in August 2021.
Obstetrx is headquartered in Wilsonville, United States.
Obstetrx creates a uterine tamponade device to eliminate maternal death and disability from postpartum hemorrhage.
Obstetrx is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Obstetrx — Funding & Investors." VCBacked, August 20, 2021, https://www.vcbacked.co/company/obstetrx. Accessed August 14, 2026.
VCBacked. (2021). Obstetrx — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/obstetrx
{{cite web |title=Obstetrx — Funding & Investors |url=https://www.vcbacked.co/company/obstetrx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated